It’s no Kardashian kerfuffle, but the FDA's ad police have sent their first letter of the year. The untitled letter sent to Collegium Pharmaceuticals tackles a hot-topic category, opioids, over a misleading booth at a pharmacists’ convention.Original Article
FDA marketing police send 2018’s first enforcement letter to Collegium over misleading opioid exhibit booth
